What does CUSIP 28106W103 represent in this 13F holders report?

CUSIP 28106W103 is the security identifier for EDIT - Editas Medicine, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held EDIT - Editas Medicine, Inc. - Common Stock in Q2 2020?

225 institutional investors reported EDIT - Editas Medicine, Inc. - Common Stock for Q2 2020. Use the holders table for investor-level position and value details.

Editas Medicine, Inc. - Common Stock (EDIT)

CUSIP: 28106W103

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock
Shares outstanding: 82,773,190
Total 13F shares: 54,180,331
Share change: +8,749,479
Total reported value: $1,601,145,803
Put/Call ratio: 36%
Price per share: $29.58
Number of holders: 225
Value change: +$263,790,568
Number of buys: 127
Number of sells: 57

Quarterly Holders Quick Answers

What is CUSIP 28106W103?
CUSIP 28106W103 identifies EDIT - Editas Medicine, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 28106W103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of EDIT - Editas Medicine, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Westside Investment Management, Inc.	13F	Company	0.02%	14,688	$106,394,000	—	31 Mar 2020	13F
ARK Investment Management LLC	13F	Company	6.4%	5,335,941	$105,812,000	—	31 Mar 2020	13F
Amova Asset Management Americas, Inc.	13F	Company	6.2%	5,107,677	$101,285,000	—	31 Mar 2020	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	6.2%	5,107,677	$101,285,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	5.7%	4,712,033	$93,439,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	5.1%	4,192,049	$83,128,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	2.4%	2,027,729	$40,210,000	—	31 Mar 2020	13F
Capital World Investors	13F	Company	2.1%	1,760,000	$34,901,000	—	31 Mar 2020	13F
FEDERATED HERMES, INC.	13F	Company	1.7%	1,436,800	$28,492,000	—	31 Mar 2020	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	1.4%	1,158,841	$22,980,000	—	31 Mar 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	1.3%	1,043,049	$20,684,000	—	31 Mar 2020	13F
Chevy Chase Trust Holdings, LLC	13F	Company	1.2%	1,030,116	$20,427,000	—	31 Mar 2020	13F
CREDIT SUISSE AG/	13F	Company	1.2%	989,894	$19,629,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.95%	784,568	$15,557,000	—	31 Mar 2020	13F
MORGAN STANLEY	13F	Company	0.92%	763,822	$15,146,000	—	31 Mar 2020	13F
NORGES BANK	13F	Company	0.81%	671,144	$13,309,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.8%	659,408	$13,076,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	0.76%	630,405	$12,502,000	—	31 Mar 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.73%	607,100	$12,039,000	—	31 Mar 2020	13F
VIKING GLOBAL INVESTORS LP	13F	Company	0.62%	512,179	$10,157,000	—	31 Mar 2020	13F
Global Thematic Partners, LLC	13F	Company	0.49%	403,581	$8,004,000	—	31 Mar 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.46%	379,263	$7,521,000	—	31 Mar 2020	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.41%	341,889	$6,780,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.41%	336,356	$6,670,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.4%	328,752	$6,519,000	—	31 Mar 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.36%	300,900	$5,967,000	—	31 Mar 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.31%	260,139	$5,159,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	0.31%	255,978	$5,075,000	—	31 Mar 2020	13F
SEGALL BRYANT & HAMILL, LLC	13F	Company	0.3%	249,550	$4,964,000	—	31 Mar 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.26%	213,866	$4,241,000	—	31 Mar 2020	13F
Elmwood Wealth Management, Inc.	13F	Company	0.14%	116,877	$3,874,473	—	31 Mar 2020	13F
CAPITAL ADVISORS INC/OK	13F	Company	0.23%	188,979	$3,747,000	—	31 Mar 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.22%	178,632	$3,542,000	—	31 Mar 2020	13F
FMR LLC	13F	Company	0.19%	156,183	$3,097,000	—	31 Mar 2020	13F
CITIGROUP INC	13F	Company	0.19%	154,009	$3,054,000	—	31 Mar 2020	13F
Tekla Capital Management LLC	13F	Company	0.16%	130,201	$2,582,000	—	31 Mar 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.14%	115,195	$2,284,000	—	31 Mar 2020	13F
HUSSMAN STRATEGIC ADVISORS, INC.	13F	Company	0.12%	102,500	$2,033,000	—	31 Mar 2020	13F
RAYMOND JAMES & ASSOCIATES	13F	Company	0.11%	94,656	$1,877,000	—	31 Mar 2020	13F
QS Investors, LLC	13F	Company	0.11%	91,610	$1,817,000	—	31 Mar 2020	13F
Swiss National Bank	13F	Company	0.11%	89,500	$1,775,000	—	31 Mar 2020	13F
HHR Asset Management, LLC	13F	Company	0.1%	83,850	$1,662,000	—	31 Mar 2020	13F
SIMPLEX TRADING, LLC	13F	Company	0.1%	82,584	$1,637,000	—	31 Mar 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.1%	79,800	$1,582,000	—	31 Mar 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.09%	78,123	$1,549,000	—	31 Mar 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.09%	74,064	$1,469,000	—	31 Mar 2020	13F
Man Group plc	13F	Company	0.09%	71,143	$1,411,000	—	31 Mar 2020	13F
Cubist Systematic Strategies, LLC	13F	Company	0.09%	70,740	$1,403,000	—	31 Mar 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.08%	68,100	$1,350,000	—	31 Mar 2020	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.08%	67,471	$1,338,000	—	31 Mar 2020	13F

Institutional Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q2 2020

As of 30 Jun 2020, Editas Medicine, Inc. - Common Stock (EDIT) was held by 225 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 54,180,331 shares. The largest 10 holders included ARK Investment Management LLC, VANGUARD GROUP INC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., BlackRock Inc., STATE STREET CORP, Capital World Investors, FEDERATED HERMES, INC., CAAS CAPITAL MANAGEMENT LP, and D. E. Shaw & Co., Inc.. This page lists 225 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

186

Q2 2020 holders

225

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.